Clinical Trials Browser

Phase 2 × Completed × prexasertib × Clear all

NCT02873975 2022-10-21

A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency

Phase 2 Completed

27 enrolled 13 charts

Classical hematology

Fanconi Anemia